Revolutionizing Protein-Protein Interaction Research with SIMPL2 Platform

A team led by researchers from the University of Toronto in Canada has developed a platform named SIMPL2 that revolutionizes the study of protein-protein interactions by simplifying detection while enhancing measurement accuracy. This groundbreaking research was recently published in the journal Molecular Systems Biology.

To address measurement challenges in studying protein interactions, the researchers initially developed the SIMPL (Split-Intein-Mediated Protein Ligation) system. SIMPL2 is an updated version of SIMPL, which involves using split luciferase to detect protein interactions through luminescence. In addition to improving interaction identification, the entire measurement process takes place in a single medium: liquid. This significantly streamlines the process by reducing the number of steps required to perform measurements.

To assess the sensitivity and applicability of the new platform, the research team utilized it to measure interactions between proteins influenced by modulators. Protein modulators include molecules that inhibit interactions between proteins, molecules that promote protein interactions, and molecules that facilitate the degradation of target proteins. The researchers found that SIMPL2 excelled in identifying these interactions, even in cases of weaker interactions.

While quantum computing and artificial intelligence have made designing small molecules for drug therapy easier, this has led to the need for faster methods to verify the efficacy of new drugs. SIMPL2 meets this demand as it can be used to test interactions between newly designed molecules and their target proteins in cultured human cells. It is capable of keeping pace with the speed at which new molecules are being designed.